Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.920
+0.120 (2.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 187 | 326 | 112 | 206 | 262 |
| Market Cap Growth | -37.62% | 191.65% | -45.72% | -21.31% | - |
| Enterprise Value | 122 | 229 | 193 | - | - |
| Last Close Price | 4.92 | 9.13 | 9.98 | 10.08 | 12.81 |
| PS Ratio | 67.08 | 118.24 | 31.67 | -263.60 | 45.93 |
| PB Ratio | 4.04 | 4.80 | 2.13 | -10.42 | 90.02 |
| P/TBV Ratio | 4.21 | 4.80 | 2.13 | - | - |
| EV/Sales Ratio | 46.07 | 82.95 | 54.51 | - | - |
| Debt / Equity Ratio | 0.04 | 0.02 | 0.23 | -0.29 | 3.25 |
| Asset Turnover | 0.03 | 0.03 | 0.06 | - | - |
| Inventory Turnover | 1.04 | 0.88 | 1.23 | 2.91 | - |
| Quick Ratio | 4.13 | 7.82 | 4.52 | 0.90 | 2.50 |
| Current Ratio | 4.23 | 7.95 | 4.56 | 0.92 | 2.52 |
| Return on Equity (ROE) | -91.66% | -81.47% | -205.21% | - | - |
| Return on Assets (ROA) | -39.20% | -33.75% | -37.42% | -52.79% | - |
| Return on Capital (ROIC) | -53.98% | -48.00% | -81.16% | - | - |
| Earnings Yield | -30.84% | -15.05% | -30.03% | -11.16% | -8.15% |
| FCF Yield | -25.76% | -14.16% | -26.70% | -9.56% | -10.20% |
| Buyback Yield / Dilution | -22.34% | -121.67% | -609.97% | -4.86% | - |
| Total Shareholder Return | -22.34% | -121.67% | -609.97% | -4.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.